Sugar-Protein Connectivity Impacts on the Immunogenicity of Site-Selective Salmonella O-Antigen Glycoconjugate Vaccines.
about
Glycomaterials for probing host-pathogen interactions and the immune response.Towards the next generation of biomedicines by site-selective conjugation.Immunology, epidemiology and mathematical modelling towards a better understanding of invasive non-typhoidal Salmonella disease and rational vaccination approaches.Carbohydrates as T-cell antigens with implications in health and disease.Oxetane Grafts Installed Site-Selectively on Native Disulfides to Enhance Protein Stability and Activity In Vivo.The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi.Dual, Site-Specific Modification of Antibodies by Using Solid-Phase Immobilized Microbial Transglutaminase.Strained alkynes derived from 2,2'-dihydroxy-1,1'-biaryls; synthesis and copper-free cycloaddition with azides.One-Step Derivatization of Reducing Oligosaccharides for Rapid and Live-Cell-Compatible Chelation-Assisted CuAAC Conjugation.Peptide adjacent to glycosylation sites impacts immunogenicity of glycoconjugate vaccine.6-Azido-6-deoxy-l-idose as a Hetero-Bifunctional Spacer for the Synthesis of Azido-Containing Chemical Probes.Potential targets for next generation anti-microbial glycoconjugate vaccines.Multicomponent polysaccharide-protein bioconjugation in the development of antibacterial glycoconjugate vaccine candidates.A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13
P2860
Q37107154-F848E267-D421-45CD-AF08-DD8D5C959C03Q38706553-076DFFFF-246C-4F11-B13D-EB83EDB5F079Q38832842-921B34EF-A51A-4E36-89C0-35A57B46EC82Q38847198-6B032C94-79E1-4683-AB2B-CC4F089EAB80Q47119242-2C330FF1-1099-4347-B0A7-99D11E2A422CQ47245287-5EAC6818-F1B3-4ACF-9C72-6DC08B77F1E1Q47994940-2C9A70B6-7A33-4554-BB8C-60E1585B3BDCQ48132440-4B137267-2047-48B7-AC45-EA300864D875Q48245292-FEC56070-3175-443C-A5D5-3169BFCBCA6BQ50076098-562EE5DA-81DA-49B7-A8EC-E8A26B6CE90DQ51220127-ADFAF8AB-DC06-4138-A501-292D07F766C2Q53701548-52BA1E0C-1889-4F1B-94EF-AA92AD47379CQ55331828-AF91D1B1-AA0A-4018-9224-D12460472503Q58587115-F13275A3-D12B-4B1B-A4C4-999AC4807B84
P2860
Sugar-Protein Connectivity Impacts on the Immunogenicity of Site-Selective Salmonella O-Antigen Glycoconjugate Vaccines.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Sugar-Protein Connectivity Imp ...... tigen Glycoconjugate Vaccines.
@ast
Sugar-Protein Connectivity Imp ...... tigen Glycoconjugate Vaccines.
@en
type
label
Sugar-Protein Connectivity Imp ...... tigen Glycoconjugate Vaccines.
@ast
Sugar-Protein Connectivity Imp ...... tigen Glycoconjugate Vaccines.
@en
prefLabel
Sugar-Protein Connectivity Imp ...... tigen Glycoconjugate Vaccines.
@ast
Sugar-Protein Connectivity Imp ...... tigen Glycoconjugate Vaccines.
@en
P2093
P2860
P356
P1476
Sugar-Protein Connectivity Imp ...... tigen Glycoconjugate Vaccines.
@en
P2093
Aimee Usera
Alok Singh
Douglas Quinn
Francesca Micoli
Giuseppe Stefanetti
Hidetomo Imase
Huili Zhai
Jennifer Cobb
Martin Allan
P2860
P304
13198-13203
P356
10.1002/ANIE.201506112
P407
P577
2015-09-09T00:00:00Z